Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$52,017,589
-$3,974,447 QoQ
Shares Held
411,727
+2.5% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
1.73%
of 13F equity value
Holder Rank
#205
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON CAPITAL MANAGEMENT LLC holds $189,707,778 across 12 Drug Manufacturers - General names. GILD ranks #2 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
69,286 | $83,103,713 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
411,727 | $52,017,589 | |
| 3 | AZN |
Astrazeneca PLC
|
201,189 | $38,149,458 | |
| 4 | JNJ |
Johnson & Johnson
|
21,048 | $5,345,560 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,329 | $3,768,776 | |
| 6 | ABBV |
AbbVie Inc.
|
13,608 | $3,424,317 | |
| 7 | AMGN |
Amgen Inc
|
4,095 | $1,482,881 | |
| 8 | NVS |
Novartis AG
|
7,290 | $1,142,488 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,017,589 | 411,727 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $55,992,036 | 401,751 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $59,470,230 | 484,522 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $49,001,949 | 441,459 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $41,337,768 | 372,849 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $26,367,381 | 235,318 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $17,273 | 187 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $15,510 | 185 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,320 | 165 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $226,122 | 3,087 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $250,077 | 3,087 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $229,691 | 3,065 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $255,487 | 3,315 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $275,045 | 3,315 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $634,002 | 7,385 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $455,580 | 7,385 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $469,508 | 7,596 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $415,079 | 6,982 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $492,441 | 6,782 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $755,288 | 10,813 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $732,670 | 10,640 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $678,615 | 10,500 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $629,208 | 10,800 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $774,077 | 12,250 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $942,515 | 12,250 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $915,810 | 12,250 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||